Lecture #20
description
Transcript of Lecture #20
Lecture #20
Treatment of eye disease4/11/13
Next week
• Create your first pageIntroduction to topic and why it is important
Doesn’t have to be final versionPicture to illustrate your topicList of 3-5 references that will be key to your project
Finding references
• PubmedSelect ReviewsFilter for free availabilitySome of the journals will be available through our library
Request any you need from ILL - NOW
Naming pages uniquely
• Name your pages with a unique name (perhaps including your initials)
• References subpageIf everyone makes a page called “References” they will write over each other
Wiki - Table of contents
• If at least four headers on a page table of contents (TOC) appears in front of the first header (or after introductory sections). Putting __TOC__ anywhere forces the TOC to appear (that is two underscores _ _ before and after)Putting __NOTOC__ anywhere forces the TOC to disappear.
Sources
• Use primary referencesTry not to use other web pages
Telephone gameIll try to help find a few papers for each topic
For Thursday next week
• Make your introductory pageHow organize home page
• Identify 3-5 referencesPut on intro page or stubs for other pages
Gene therapy
The future promise of curing all disease
Gene therapy
• Many diseases of the eye are the result of single gene mutationsOver 200 genes now knownRhodopsin, phototransduction pathway, visual cycle
• If you could insert a gene to repair damage - the disease would be cured
Ideal scenario for gene therapy
• Know the mutated gene to replace• Have good copy of gene• Understand biology
Know tissue and how gene is acting• Know that adding gene back will solve
problem• The eye is a contained organ so therapy does
not impact other organs
Ocular gene therapy
• Three kinds of therapiesIntroduce a gene to make a protein which alleviates some of symptomsIntroduce a replacement gene to fix mutationIntroduce a gene to knock out faulty gene (RNAi)
What is needed to make this happen?
• Gene expressed to sufficient extentMake enough “stuff” to provide relief
• Gene expressed for long timeRetinal cells don’t divide so doesn’t need to integrate with DNABut does need strong promoter so expressed in tissue of interest
• No cause of inflammatory or immunogenic response
Vectors for gene delivery - Viruses
• ProsExisting method for getting DNA into cells
May be engineered to target particular cellsCan be modified so don’t replicate and destroy cell
• ConsVirus can only handle a gene up to certain sizeMay trigger immune response making person sickPerson may develop immunity so virus gets destroyed
Getti
ng th
e st
uff to
the
right
pla
ce
Alqawlaq et al 2012
Getting gene to tissue of interest
• In vivoAdd directly to tissue in the body
• Ex vivoRemove cells of interestCulture cellsAdd vector containing gene of interestIf gene integrates, add back to body
Advantages of viruses
• Common in humans43 different types
• Rapidly infect many kinds of human cells with high gene transfer rate
• Low pathogenicity• Can hold up to 7.5 kb of DNA• Viral DNA is stable with no rearranging• Viral DNA is easy to manipulate
Gene therapy with adenovirus
Nature Genetics 28: 92 (2001)
Visual cycle (lecture 16)
RPE 65 is key isomerase in RPE to convert all trans retinal ester to 11-cis retinolMutations cause Leber congenital amaurosis
Dog model : Swedish Briard• Have mutation in RPE65
4 bp deletionCongenital stationary night blindness
Congenital - from birthStationary - stableNight blindness - affects rods
Can also have some degeneration with time
First show can treat RPE cells with adeno-associated virus containing RPE65 to rescue mutant RPE65-/-
WT RPE cels RPE65-/- AAV treated
Nuclei are orange from propidium iodide stainingRPE65 antibody glows green
WT retina RPE65-/-
In vivo treatment - Divide eye into retinal quadrants
Inject AAV-RPE65 into TS
TSTemporal-superior
TI Temporal inferior
NINasal inferior
NSNasal superior
PCR of DNA from wild type and mutant RPE65
Wild type
Mutant w/ 4 bp deletion
109 bp
105 bp
Use PCR to screen for expressed gene after innoculate with AAV - RPE65
Persistent expression of new RPE65 form (99 days after inject)
RPE65
Individual dogs: WT, hetero- and homozygous mutant
Cultured RPE cells WT, mutant pre- and post-treatment
Use PCR to screen for expressed gene after innoculate with AAV - RPE65
RPE65
R=retinaP=RPE
In vivo treatment. See injected functional RPE65 in TS region only Not in other 3 eye quadrants
Use PCR to screen for expressed gene after innoculate with AAV - RPE65
Get expressed cDNA only in RPE of quadrant where injection occurred.
RPE65
RT PCR / cDNA
genomic
Electroretinograms show improvement resulting from AAV-RPE65
Downward a wave from photoreceptorsUpward b wave from bipolars, oscillations from amarcrine
Injections must be subretinal
Intravitreal injections don’t work
Video by Acland et al showing dog behavior
Subretinal injection of AAV-RPE65 gene
Retinal photoreceptor distributions before treatment
PR thickness
Light sensitive area increases as does light sensitivity by:
P1 10xP2 100xP3 1000x
Time after injection1 month2 months3 months
Enhanced light sensitivity to that expected based on number of photoreceptors they have
So 11-cis retinal supply is much better!
Retinal gene therapy
• Is well on its way!
Transgenic animals to enhance color processing
Jeremy Nathans• Professor, Johns Hopkins and
HHMIBS Chemistry and Biology MITPhD Biochemistry and MD, Stanford
• Sequenced the bovine rhodopsin gene
• Sequence the human rod and cone opsin genes
Gerald Jacobs• Professor, UCSB
BA U VermontPhD Indiana UAsst Prof UT AustinUCSB starting in 1969
• Electrophysiology, psychophysics• Human and primate red/green
vision
Normal mouse visual pigments
UV cone - 360 nm
Green cone - 508 nm
Engineered a new mouse where green gene replaced by red
UV cone - 365 nmRed cone - 565 nm
If cross mice will get homozygous..
…and heterozygous mice
Just like primates
• Different alleles on X chromosome• Females can be heterozygous• X inactivation will result in some cones
expressing green gene and some expressing the red gene
• Does this enable enhanced color vision?????
Test spectral sensitivity of different mice
• Use electroretinogram to measure sensitivity of entire retina
• For heterozygous mice can estimate the fraction of cones which have L pigment
512 nmn=12
556 nm n=17
n=87
Heterozygous mice
• Get range of L:M cone ratios in heterozygotes
• Differences in X inactivation and / or expression?
Behavioral testing
Operant training - mouse gets drop of soy milk as reward for choosing the light that differs from the other two
Do L cones contribute to light detection?
• Compare thresholds at which can see difference from achromatic backgrounds
Add different amounts of either 500 nm or 600 nm light What is threshold needed to distinguish it from white?
Compare threshold at 500nm and 600nm
Mice with M+L cones more sensitive to 600 nm light than those with only M
How much more red light vs green light is needed to get behavioral response Threshold difference report as Log 500 nm/600nm
If log x = 1 then x = 101
Mice with M+L cones more sensitive to 600 nm light than those with only M
So if only M cones, response requires 101.3=20x more 600 nm than 500 nm light
If M+L cones, response requires only 10.85= 7x more 600 nm light than 500 nm light
So L cone makes more sensitive to 600 nm light
Conclusion
• New L cones do contribute to the detection of light.
• Do they contribute to color vision??
Test color discrimination
Have two targets with 600 nm light.Third is illuminated with various wavelengths. If mouse can’t tell those from 600 nm, then mouse will guess randomly which target is correct.
% correct choices when compare light at test wavelength with 600 nm
M only
M:L 78:22
M:L 65:35
Need significant # of L cones to discriminate colors
M only
M:L 78:22
M:L 65:35
M:L 44:56
M:L 46:54
M:L 53:47
Color mixing experiments
• Vary amount of 530 and 620 nm light shine on same target
•When can mouse tell this mixture apart from 600 nm?
530 nm 620 nm
Color matching results
Mouse can tell mixture apart until get close to pure 600 nmHuman observer compared to prediction also shown.
What do you think?
• If give mice a third pigment, do they become trichromats?
• What more proof could be gathered?
Alternative interpretation
Mouse view
• Might not see color - might see varying brightness
Homozygous mouse
Heterozygous mouse
500 nm 500+600 nm
Neitz’s repeat experiment in monkey
Dichromatic male squirrel monkeys
Start with males who are dichromates Blue and green cones
Some females are already trichromats so don’t use them
Trichromats
Gene therapy with LWS gene
• Treat adultsNo change in wiring - would it be utilized?If works, set stage for treating adults with occular disease using gene therapy
• Subretinal injection of recombinant adeno-associated virus containing human red opsin
Response to red light using ERG
Retinal map 40 wks after two injections
Inset shows 16 wks after so takes a long while for Lops to be expressed
Response to red light using ERG
Retinal map 40 wks after two injections
Coinjected GFP viruses
Estimate 15-36% of cones are LWS
Cambridge color vision test
Dichromats confuse certain colors with grey
Hues that stimulate both cones equally
Cyan = Blue-green stimulates both cones equally.Gray also stimulates both cones equallySo hues near the pigment crossing points are hard to distinguish from gray
Dalton - squirrel monkey
Ask Dalton to locate colored square
Need to distinguish it from gray
Get reward if correct
Cambridge vision test modified for animals
Can increase the saturation of color to see at what threshold it is distinct from gray
Possible outcomes of Lops addition
Could shift sensitivity to longer wavelength
Could remove uncertainties so can discriminate all colors
Squirrel monkey before and after treatment with virus containing
Human LWS gene